Alicia Ciccone, Digital Content Editor

Investigators pooled data from patients from 3 phase 3, 24-week, randomized, placebo-controlled trials of MEM in patients with Alzheimer disease receiving concurrent ChEIs.

While hundreds of published reports have made an argument for an association between Alzheimer disease and bacteria and viruses, the suggestion of a viral contribution to Alzheimer disease has not always been well received by the greater research community.

In order to maximize cognitive benefits in patients with epilepsy, early consideration of and evaluation for epilepsy surgery is key.

Primary hyperparathyroidism may be linked to lower intracerebral vasomotor reactivity, which could lead to cognitive dysfunction.

Anxiety and severe cognitive fatigue may contribute to problems with visual learning in patients with MS.

Ingrezza significantly and rapidly improved tardive dyskinesia symptoms compared to placebo, rmarking a tremendous breakthrough for patients suffering from TD.

Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.

Addressing problems with sleep health may help prevent gestational diabetes.

Migraine was more significantly associated with muscle soreness or pain than anxiety disorders in patients with MDD.

Eli Lilly’s investigational Alzheimer’s drug did not meet the primary end point in the phase 3 EXPEDITION3 trial.

Every decrease in standard deviation of the amount of REM sleep was correlated with a 23% increased risk of atrial fibrillation.

Infants with postnatal etiology showed worse developmental deficits across all domains.

Eighty-one percent of patients deemed ziprasidone effective in reducing migraine severity.

The American Heart Association issues a scientific statement on the possible link between chronic arterial hypertension and cognitive impairment.

One hypothesis is that thyroid function affects dementia risk through nonvascular pathways.

Researchers at ARIA Diagnostics in Indianapolis, IN conducted urine screens to test for opiates/opiods, gabapentin, pregabalin, and other substances.

The study suggests that statins may serve a greater purpose beyond control of lipids and cardiovascular events.

These results are contrary to results from a prior large population study.

Cases of all-cause dementia and Alzheimer’s did not significantly differ between study groups, but vascular care is safe and may reduce incidence of non-Alzheimer’s dementia.

The results indicate a 10-fold increased risk of future autism in patients diagnosed with epilepsy.

The drug is the first of its kind to address PD psychosis without having an ill effect on motor symptoms.

Study participants with moderate to severe anxiety exhibited poor visual and verbal memory.

Depression is one of many factors that can predict an inadequate treatment response in patients with episodic migraine.

The researchers observed between-group differences between real and sham acupuncture treatment.

Special education resources appear to play a significant role in early diagnosis of ASD.

Those with the gum disease saw a 6-fold increase in cognitive decline over follow-up.

Researchers suggest that there are more effective or adjunctive interventions to resolve symptoms of RBD.

Avoiding the common prescription and OTC gastrointestinal drugs may help prevent development of dementia.

Amyloid plaque similar to that seen in Alzheimer’s was found in participants with TBI.

After performing brain autopsies, researchers found pesticide residue in 90% of the participants.